TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PTCT

PTC Therapeutics Inc

Healthcare · Biotechnology

65.00$ -1.5% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

PTC Therapeutics Inc (PTCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,250 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PTCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,260 1,896 1,790 1,916 1,842 1,705 2,655 2,634 2,644 2,899 2,869 3,250
540 1,219 1,169 1,358 1,282 1,366 2,316 2,273 2,008 2,274 2,254 2,617
165 594 548 655 526 780 1,480 1,017 673 985 834 1,050
295 877 885 1,093 1,013 1,140 2,027 1,989 1,688 1,945 1,892 2,229
166 161 198 187 200 159 210 196 203 182 220 239
36 31 30 32 36 23 22 34 53 80 76 91
82 82 82 82 82 82 82 82 82 82 82 82
423 379 330 330 330 119 118 144 396 389 381 403
1,931 2,714 2,684 2,897 2,897 2,803 2,841 2,841 2,799 3,104 3,050 3,416
492 603 575 610 611 581 595 628 866 968 924 771
14 210 17 16 17 271 17 17 301 585 305 73
19 6.0 27 24 13 17 15 27 37 45 25 40
573 1,904 285 285 285 2,109 286 286 – 2,025 – 536
-671 -819 -894 -980 -1,054 -1,098 -186 -207 -156 -205 -180 -165
-3,128 -3,284 -3,375 -3,474 -3,581 -3,647 -2,780 -2,845 -2,829 -2,964 -2,967 -2,884
75 76 76 77 77 77 86 78 87 81 83 92

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?